Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial [NA]

View source ↗

Summary

A randomized controlled trial evaluating tegoprazan-based regimens for Helicobacter pylori eradication has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tegoprazan (tegoprazan)

Snippet

Sponsor: Zhongshan Hospital (Xiamen), Fudan University | Conditions: Helicobacter Pylori Eradication, Adverse Reaction | NA | Status: COMPLETED